About
Hongjie (Harry) Qian is a PhD student in Pharmacoepidemiology at Rutgers University under the supervision of Prof Chintan Dave, focusing on real-world evidence and drug safety in chronic disease management. He previously completed his MS degree in Biostatistics at UC San Diego (San Diego, CA; 2025) and holds dual BS degrees in Pharmacy and Biochemistry & Pharmacology (Hons) from China Pharmaceutical University (Nanjing, China; 2023) and University of Strathclyde (Glasgow, Scotland; 2023), respectively. Currently, his research centers on comparative safety and effectiveness, drug-drug interactions, and multimorbidity in Medicare populations.
For more information, please refer to hongjie-qian.github.io